VIRTUS ADVISERS, LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1587281 HARTFORD, CT

Position in AKBA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$428,120

+$381,344 QoQ

Shares Held

308,000

+372.8% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

VIRTUS ADVISERS, LLC holds $9,030,219 across 12 Drug Manufacturers - Specialty & Generic names. AKBA ranks #7 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PAHC	Phibro Animal Health Corp	41,542	$2,297,687
2	ALKS	Alkermes plc.	47,468	$1,678,467
3	RDY	Dr Reddys Laboratories Ltd	107,110	$1,483,473
4	ANIP	Ani Pharmaceuticals Inc	13,556	$1,042,456
5	PBH	Prestige Consumer Healthcare Inc.	10,324	$611,903
6	AMRX	Amneal Pharmaceuticals, Inc.	35,921	$446,498
7	AKBA	Akebia Therapeutics, Inc. This page	308,000	$428,120
8	NBIX	Neurocrine Biosciences Inc	2,584	$340,416

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$428,120	308,000	+372.8%	Shares	Other	2026-05-14
2022-03-31	$46,776	65,149	-5.6%	Shares	Other	2022-05-16
2021-12-31	$155,973	69,015	+18.5%	Shares	Other	2022-02-14
2021-09-30	$167,739	58,243	-5.0%	Shares	Other	2021-11-15
2021-06-30	$232,266	61,284	-35.1%	Shares	Other	2021-08-10
2021-03-31	$319,652	94,432	+1.8%	Shares	Other	2021-05-17
2020-12-31	$259,758	92,771	+236.8%	Shares	Other	2021-02-12
2020-09-30	$69,140	27,546	-12.0%	Shares	Other	2020-11-13
2020-06-30	$424,958	31,293	-44.4%	Shares	Other	2020-08-05
2020-03-31	$426,526	56,270	—	Shares	Other	2020-05-14
No filing history on record for this holder in this stock.